MAIA MAIA Biotechnology Net earnings per share growth this year

MAIA (MAIA Biotechnology) - company brandmark

MAIA Biotechnology focuses on brain and lung tumor therapies, leveraging partnerships with oncology centers to accelerate time-to-market for its drugs. This annual earnings per share trend chart visualizes market expectations, where the current figure stands at 23.10. The company's environmental policy is limited to biosafety compliance and the digitalization of office processes.

MAIA Biotechnology, Inc. (MAIA): Net earnings per share growth this year from 04/28/2023 to 11/12/2026

Analytical breakdowns and data insights for company MAIA Biotechnology (MAIA)

- current quotes and average value forecast:
Market Chart MAIA Biotech|MAIA - Price Target Chart
- market capitalization data:
Market Valuation MAIA Bio|MAIA - Total Company Value
- company book value details:
Accounting Value per Share MAIA Biotechnology|MAIA - Company Net Assets|Market Capitalization to Book Value Ratio MAIABiotech.com|MAIA - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio MAIA Biotechnology|MAIA - Long-Term Debt to Equity|Current Liabilities to Capital MAIABiotech.com|MAIA - Company Total Debt|Debt to Net Assets MAIA Bio|MAIA - Company Long-Term Liabilities|Amount of Current Liabilities MAIA Biotechnology|Intermediate Coverage Ratio MAIABiotech.com
- net income and valuation ratios data:
MAIA - Net Profit|Expected Net Profit MAIA Biotechnology|MAIA - Price to Earnings Ratio|Future Price to Earnings Multiple MAIA Bio|MAIA - PEG Multiple|EV/EBITDA Multiple MAIA Bio|MAIA - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months MAIA Biotechnology|MAIA - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months MAIABiotech.com|MAIA - Earnings per share growth in current year|Expected earnings per share growth for next year MAIA Biotechnology
Summary company analysis:MAIA (MAIA Biotech)
Brand item of MAIA Biotechnology Inc

This indicator captures the annual earnings per share (EPS) trend, reflecting the efficiency of the business capitalization. The calculation is based on a percentage comparison of the current EPS against the same period last year to identify hidden costs. Tracking annual EPS growth with a value of 23.10 allows for an assessment of the company's financial stability. For MAIA Biotechnology (MAIA), this is critically important during the development of costly cancer immunotherapy. The innovative oncology platform directly impacts the final profitability.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year Immunocore PLC|Net earnings per share growth this year Janux Corp (JANX)|Earnings per share growth in current year Arcus Biosciences, Inc. (RCUS)|Net earnings per share growth this year zymeworks.com ZYME|Tango Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Iovance Biotherapeutics Inc IOVA|IMTX - Earnings per share growth in current year|XNCR (Xencor Inc.) - Earnings per share growth this year|Compass Therapeutics (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year replimune.com (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech, Inc.)|Earnings per share increase in current year STRO|MiNK Therapeutics - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics|immixbio.com (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings Inc. - Earnings per share increase in current year|CUE (Cue Biopharma, Inc.) - Earnings growth in current year|Earnings growth in current year PDS Biotechnology Corp|Earnings per share growth in current year Sonnet BioTherapeutics (SONN)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|NextCure Corporation (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Intensity Therapeutics (INTS) - Net earnings per share growth this year|SNSE: Earnings growth in current year|Theriva Biologics Inc (TOVX) - Earnings growth in current year|GRTS (Gritstone bio Inc.) - Earnings growth in current year|Kineta Corp (KA) - Expected net earnings per share growth this year|Earnings growth in current year NEXI|Earnings growth in current year turnstonebio.com (TSBX)|Vaccinex - Net earnings per share growth this year|Earnings per share increase in current year HARP